Skip to main content
Top
Published in: Respiratory Research 1/2019

Open Access 01-12-2019 | Research

Dose variability of supplemental oxygen therapy with open patient interfaces based on in vitro measurements using a physiologically realistic upper airway model

Authors: Ira Katz, John Chen, Kelvin Duong, Kaixian Zhu, Marine Pichelin, Georges Caillibotte, Andrew R. Martin

Published in: Respiratory Research | Issue 1/2019

Login to get access

Abstract

Background

Supplemental oxygen therapy is widely used in hospitals and in the home for chronic care. However, there are several fundamental problems with the application of this therapy such that patients are often exposed to arterial oxygen concentrations outside of the intended target range. This paper reports volume-averaged tracheal oxygen concentration measurements (FtO2) from in vitro experiments conducted using a physiologically realistic upper airway model. The goal is to provide data to inform a detailed discussion of the delivered oxygen dose.

Methods

A baseline FtO2 dataset using a standard, straight adult nasal cannula was established by varying tidal volume (Vt), breathing frequency (f), and continuous oxygen flow rate (QO2) between the following levels to create a factorial design: Vt = 500, 640, or 800 ml; f = 12, 17, or 22 min− 1; QO2 = 2, 4, or 6 l/min. Further experiments were performed to investigate the influence on FtO2 of variation in inspiratory/expiratory ratio, inclusion of an inspiratory or expiratory pause, patient interface selection (e.g. nasal cannula versus a facemask), and rapid breathing patterns in comparison with the baseline measurements.

Results

Oxygen concentration measured at the trachea varied by as much as 60% (i.e. from 30.2 to 48.0% of absolute oxygen concentration) for the same oxygen supply flow rate due to variation in simulated breathing pattern. Among the baseline cases, the chief reasons for variation were 1) the influence of variation in tidal volume leading to variable FiO2 and 2) variation in breathing frequency affecting volume of supplemental oxygen delivered through the breath.

Conclusion

For oxygen administration using open patient interfaces there was variability in the concentration and quantity of oxygen delivered to the trachea over the large range of scenarios studied. Of primary importance in evaluating the oxygen dose is knowledge of the breathing parameters that determine the average inhalation flow rate relative to the oxygen flow rate. Otherwise, the oxygen dose cannot be determined.
Appendix
Available only for authorised users
Literature
1.
go back to reference Beasley R, Thayabaran D, Bardsley G. The acute use of oxygen therapy in adults. Malta Med J. 2017;29(2). Beasley R, Thayabaran D, Bardsley G. The acute use of oxygen therapy in adults. Malta Med J. 2017;29(2).
2.
go back to reference Jacobs SS, Lindell KO, Collins EG, Garvey CM, Hernandez C, McLaughlin S, et al. Patient perceptions of the adequacy of supplemental oxygen therapy. Results of the American Thoracic Society nursing assembly oxygen working group survey. Ann Am Thorac Soc. 2018;15(1):24–32.CrossRef Jacobs SS, Lindell KO, Collins EG, Garvey CM, Hernandez C, McLaughlin S, et al. Patient perceptions of the adequacy of supplemental oxygen therapy. Results of the American Thoracic Society nursing assembly oxygen working group survey. Ann Am Thorac Soc. 2018;15(1):24–32.CrossRef
3.
go back to reference Lellouche F, L’Her E. Automated oxygen flow titration to maintain constant oxygenation. Respir Care 1 août. 2012;57(8):1254–62.CrossRef Lellouche F, L’Her E. Automated oxygen flow titration to maintain constant oxygenation. Respir Care 1 août. 2012;57(8):1254–62.CrossRef
4.
go back to reference Brueckl C, Kaestle S, Kerem A, Habazettl H, Krombach F, Kuppe H, et al. Hyperoxia-induced reactive oxygen species formation in pulmonary capillary endothelial cells in situ. Am J Respir Cell Mol Biol avr. 2006;34(4):453–463. Brueckl C, Kaestle S, Kerem A, Habazettl H, Krombach F, Kuppe H, et al. Hyperoxia-induced reactive oxygen species formation in pulmonary capillary endothelial cells in situ. Am J Respir Cell Mol Biol avr. 2006;34(4):453–463.
5.
go back to reference Bolton DP, Cross KW. Further observations on cost of preventing retrolental fibroplasia. Lancet Lond Engl 16 mars. 1974;1(7855):445–448. Bolton DP, Cross KW. Further observations on cost of preventing retrolental fibroplasia. Lancet Lond Engl 16 mars. 1974;1(7855):445–448.
6.
go back to reference Helmerhorst HJ, Schultz MJ, van der Voort PH, Bosman RJ, Juffermans NP, de Jonge E, et al. Self-reported attitudes versus actual practice of oxygen therapy by ICU physicians and nurses. Ann Intensive Care. 2014;4(1):23.CrossRef Helmerhorst HJ, Schultz MJ, van der Voort PH, Bosman RJ, Juffermans NP, de Jonge E, et al. Self-reported attitudes versus actual practice of oxygen therapy by ICU physicians and nurses. Ann Intensive Care. 2014;4(1):23.CrossRef
7.
go back to reference Kelly CA, Maden M. How do health-care professionals perceive oxygen therapy? A critical interpretive synthesis of the literature how do health-care professionals perceive oxygen therapy? A critical interpretive synthesis of the literature. Chron Respir Dis 1 févr 2015;12(1):11–23. Kelly CA, Maden M. How do health-care professionals perceive oxygen therapy? A critical interpretive synthesis of the literature how do health-care professionals perceive oxygen therapy? A critical interpretive synthesis of the literature. Chron Respir Dis 1 févr 2015;12(1):11–23.
8.
go back to reference Bellomo R, Bailey M, Eastwood GM, Nichol A, Pilcher D, Hart GK, et al. Arterial hyperoxia and in-hospital mortality after resuscitation from cardiac arrest. Crit Care. 2011;15(2):R90.CrossRef Bellomo R, Bailey M, Eastwood GM, Nichol A, Pilcher D, Hart GK, et al. Arterial hyperoxia and in-hospital mortality after resuscitation from cardiac arrest. Crit Care. 2011;15(2):R90.CrossRef
9.
go back to reference de Jonge E, Peelen L, Keijzers PJ, Joore H, de Lange D, van der Voort PH, et al. Association between administered oxygen, arterial partial oxygen pressure and mortality in mechanically ventilated intensive care unit patients. Crit Care. 2008;12(6):R156.CrossRef de Jonge E, Peelen L, Keijzers PJ, Joore H, de Lange D, van der Voort PH, et al. Association between administered oxygen, arterial partial oxygen pressure and mortality in mechanically ventilated intensive care unit patients. Crit Care. 2008;12(6):R156.CrossRef
10.
go back to reference Eastwood G, Bellomo R, Bailey M, Taori G, Pilcher D, Young P, et al. Arterial oxygen tension and mortality in mechanically ventilated patients. Intensive Care Med. 2012;38(1):91–8.CrossRef Eastwood G, Bellomo R, Bailey M, Taori G, Pilcher D, Young P, et al. Arterial oxygen tension and mortality in mechanically ventilated patients. Intensive Care Med. 2012;38(1):91–8.CrossRef
11.
go back to reference Farquhar H, Weatherall M, Wijesinghe M, Perrin K, Ranchord A, Simmonds M, et al. Systematic review of studies of the effect of hyperoxia on coronary blood flow. Am Heart J. 2009;158(3):371–7.CrossRef Farquhar H, Weatherall M, Wijesinghe M, Perrin K, Ranchord A, Simmonds M, et al. Systematic review of studies of the effect of hyperoxia on coronary blood flow. Am Heart J. 2009;158(3):371–7.CrossRef
12.
go back to reference Hovaguimian F, Lysakowski C, Elia N, Tramèr MR. Effect of intraoperative high inspired oxygen fraction on surgical site infection, postoperative nausea and vomiting, and pulmonary FunctionSystematic review and meta-analysis of randomized controlled trials. Anesthesiol J Am Soc Anesthesiol. 2013;119(2):303–16. Hovaguimian F, Lysakowski C, Elia N, Tramèr MR. Effect of intraoperative high inspired oxygen fraction on surgical site infection, postoperative nausea and vomiting, and pulmonary FunctionSystematic review and meta-analysis of randomized controlled trials. Anesthesiol J Am Soc Anesthesiol. 2013;119(2):303–16.
13.
go back to reference Ihle JF, Bernard S, Bailey MJ, Pilcher DV, Smith K, Scheinkestel CD. Hyperoxia in the intensive care unit and outcome after out-of-hospital ventricular fibrillation cardiac arrest. Crit Care Resusc. 2013;15(3):186.PubMed Ihle JF, Bernard S, Bailey MJ, Pilcher DV, Smith K, Scheinkestel CD. Hyperoxia in the intensive care unit and outcome after out-of-hospital ventricular fibrillation cardiac arrest. Crit Care Resusc. 2013;15(3):186.PubMed
14.
go back to reference Janz DR, Hollenbeck RD, Pollock JS, McPherson JA, Rice TW. Hyperoxia is associated with increased mortality in patients treated with mild therapeutic hypothermia after sudden cardiac arrest. Crit Care Med. 2012;40(12):3135.CrossRef Janz DR, Hollenbeck RD, Pollock JS, McPherson JA, Rice TW. Hyperoxia is associated with increased mortality in patients treated with mild therapeutic hypothermia after sudden cardiac arrest. Crit Care Med. 2012;40(12):3135.CrossRef
15.
go back to reference Kilgannon JH, Jones AE, Shapiro NI, Angelos MG, Milcarek B, Hunter K, et al. Association between arterial hyperoxia following resuscitation from cardiac arrest and in-hospital mortality. Jama. 2010;303(21):2165–71.CrossRef Kilgannon JH, Jones AE, Shapiro NI, Angelos MG, Milcarek B, Hunter K, et al. Association between arterial hyperoxia following resuscitation from cardiac arrest and in-hospital mortality. Jama. 2010;303(21):2165–71.CrossRef
16.
go back to reference Rachmale S, Li G, Wilson G, Malinchoc M, Gajic O. Practice of excessive FIO2 and effect on pulmonary outcomes in mechanically ventilated patients with acute lung injury. Respir Care. 2012;57(11):1887–93.CrossRef Rachmale S, Li G, Wilson G, Malinchoc M, Gajic O. Practice of excessive FIO2 and effect on pulmonary outcomes in mechanically ventilated patients with acute lung injury. Respir Care. 2012;57(11):1887–93.CrossRef
17.
go back to reference Raj R, Bendel S, Reinikainen M, Kivisaari R, Siironen J, Lang M, et al. Hyperoxemia and long-term outcome after traumatic brain injury. Crit Care. 2013;17(4):R177.CrossRef Raj R, Bendel S, Reinikainen M, Kivisaari R, Siironen J, Lang M, et al. Hyperoxemia and long-term outcome after traumatic brain injury. Crit Care. 2013;17(4):R177.CrossRef
18.
go back to reference Rincon F, Kang J, Vibbert M, Urtecho J, Athar MK, Jallo J. Significance of arterial hyperoxia and relationship with case fatality in traumatic brain injury: a multicentre cohort study. J Neurol Neurosurg Psychiatry. 2014;85(7):799–805.CrossRef Rincon F, Kang J, Vibbert M, Urtecho J, Athar MK, Jallo J. Significance of arterial hyperoxia and relationship with case fatality in traumatic brain injury: a multicentre cohort study. J Neurol Neurosurg Psychiatry. 2014;85(7):799–805.CrossRef
19.
go back to reference Wijesinghe M, Perrin K, Ranchord A, Simmonds M, Weatherall M, Beasley R. Routine use of oxygen in the treatment of myocardial infarction: systematic review. Heart. 2009;95(3):198–202.CrossRef Wijesinghe M, Perrin K, Ranchord A, Simmonds M, Weatherall M, Beasley R. Routine use of oxygen in the treatment of myocardial infarction: systematic review. Heart. 2009;95(3):198–202.CrossRef
20.
go back to reference Young P, Beasley R, Bailey M, Bellomo R, Eastwood GM, Nichol A, et al. The association between early arterial oxygenation and mortality in ventilated patients with acute ischaemic stroke. Crit Care Resusc. 2012;14(1):14.PubMed Young P, Beasley R, Bailey M, Bellomo R, Eastwood GM, Nichol A, et al. The association between early arterial oxygenation and mortality in ventilated patients with acute ischaemic stroke. Crit Care Resusc. 2012;14(1):14.PubMed
21.
go back to reference Rincon F, Kang J, Maltenfort M, Vibbert M, Urtecho J, Athar MK, et al. Association between hyperoxia and mortality after stroke: a multicenter cohort study. Crit Care Med. 2014;42(2):387–96.CrossRef Rincon F, Kang J, Maltenfort M, Vibbert M, Urtecho J, Athar MK, et al. Association between hyperoxia and mortality after stroke: a multicenter cohort study. Crit Care Med. 2014;42(2):387–96.CrossRef
22.
go back to reference Batool S, Garg R. Appropriate use of oxygen delivery devices. Open Anesthesiol J 2017;11(1). Batool S, Garg R. Appropriate use of oxygen delivery devices. Open Anesthesiol J 2017;11(1).
23.
go back to reference Chen JZ, Katz IM, Pichelin M, Zhu K, Caillibotte G, Noga ML, et al. Comparison of pulsed versus continuous oxygen delivery using realistic adult nasal airway replicas. Int J Chron Obstruct Pulmon Dis. 2017;12:2559.CrossRef Chen JZ, Katz IM, Pichelin M, Zhu K, Caillibotte G, Noga ML, et al. Comparison of pulsed versus continuous oxygen delivery using realistic adult nasal airway replicas. Int J Chron Obstruct Pulmon Dis. 2017;12:2559.CrossRef
24.
go back to reference Chen JZ, Katz IM, Pichelin M, Zhu K, Caillibotte G, Finlay WH, et al. In vitro-in silico comparison of pulsed oxygen delivery from portable oxygen concentrators to continuous flow oxygen delivery. Respir Care. 2019;64(2):117–29. Chen JZ, Katz IM, Pichelin M, Zhu K, Caillibotte G, Finlay WH, et al. In vitro-in silico comparison of pulsed oxygen delivery from portable oxygen concentrators to continuous flow oxygen delivery. Respir Care. 2019;64(2):117–29.
25.
go back to reference Burnell PKP, Asking L, Borgström L, Nichols SC, Olsson B, Prime D, et al. Studies of the human oropharyngeal airspaces using magnetic resonance imaging IV—the oropharyngeal retention effect for four inhalation delivery systems. J Aerosol Med 1 sept. 2007;20(3):269–81.CrossRef Burnell PKP, Asking L, Borgström L, Nichols SC, Olsson B, Prime D, et al. Studies of the human oropharyngeal airspaces using magnetic resonance imaging IV—the oropharyngeal retention effect for four inhalation delivery systems. J Aerosol Med 1 sept. 2007;20(3):269–81.CrossRef
26.
go back to reference Delvadia R, Hindle M, Longest PW, Byron PR. In vitro tests for aerosol deposition II: IVIVCs for different dry powder inhalers in Normal adults. J Aerosol Med Pulm Drug Deliv 4 sept 2012;26(3):138–144. Delvadia R, Hindle M, Longest PW, Byron PR. In vitro tests for aerosol deposition II: IVIVCs for different dry powder inhalers in Normal adults. J Aerosol Med Pulm Drug Deliv 4 sept 2012;26(3):138–144.
27.
go back to reference Weers JG, Clark AR, Rao N, Ung K, Haynes A, Khindri SK, et al. In vitro–in vivo correlations observed with Indacaterol-based formulations delivered with the Breezhaler®. J Aerosol Med Pulm Drug Deliv 17 déc 2014;28(4):268–280. Weers JG, Clark AR, Rao N, Ung K, Haynes A, Khindri SK, et al. In vitro–in vivo correlations observed with Indacaterol-based formulations delivered with the Breezhaler®. J Aerosol Med Pulm Drug Deliv 17 déc 2014;28(4):268–280.
28.
go back to reference Zhang Y, Gilbertson K, Finlay WH. In vivo–in vitro comparison of deposition in three mouth–throat models with Qvar® and Turbuhaler® inhalers. J Aerosol Med. 1 sept 2007;20(3):227–235.CrossRef Zhang Y, Gilbertson K, Finlay WH. In vivo–in vitro comparison of deposition in three mouth–throat models with Qvar® and Turbuhaler® inhalers. J Aerosol Med. 1 sept 2007;20(3):227–235.CrossRef
29.
go back to reference Kang M-Y, Katz I, Sapoval B. A new approach to the dynamics of oxygen capture by the human lung. Respir Physiol Neurobiol. 2015;205:109–19.CrossRef Kang M-Y, Katz I, Sapoval B. A new approach to the dynamics of oxygen capture by the human lung. Respir Physiol Neurobiol. 2015;205:109–19.CrossRef
30.
go back to reference Katz I, Pichelin M, Montesantos S, Kang M-Y, Sapoval B, Zhu K, et al. An in silico analysis of oxygen uptake of a mild COPD patient during rest and exercise using a portable oxygen concentrator. Int J Chron Obstruct Pulmon Dis 29 sept 2016;11:2427–2434. Katz I, Pichelin M, Montesantos S, Kang M-Y, Sapoval B, Zhu K, et al. An in silico analysis of oxygen uptake of a mild COPD patient during rest and exercise using a portable oxygen concentrator. Int J Chron Obstruct Pulmon Dis 29 sept 2016;11:2427–2434.
31.
go back to reference Golshahi L, Noga ML, Thompson RB, Finlay WH. In vitro deposition measurement of inhaled micrometer-sized particles in extrathoracic airways of children and adolescents during nose breathing. J Aerosol Sci. 2011;42(7):474–88.CrossRef Golshahi L, Noga ML, Thompson RB, Finlay WH. In vitro deposition measurement of inhaled micrometer-sized particles in extrathoracic airways of children and adolescents during nose breathing. J Aerosol Sci. 2011;42(7):474–88.CrossRef
32.
go back to reference Zhou S, Chatburn RL. Effect of the anatomic reservoir on low-flow oxygen delivery via nasal cannula: constant flow versus pulse flow with portable oxygen concentrator. Respir Care. 6 mai 2014;respcare.02878. Zhou S, Chatburn RL. Effect of the anatomic reservoir on low-flow oxygen delivery via nasal cannula: constant flow versus pulse flow with portable oxygen concentrator. Respir Care. 6 mai 2014;respcare.02878.
33.
go back to reference Bazuaye EA, Stone TN, Corris PA, Gibson GJ. Variability of inspired oxygen concentration with nasal cannulas. Thorax 1 août 1992;47(8):609–611. Bazuaye EA, Stone TN, Corris PA, Gibson GJ. Variability of inspired oxygen concentration with nasal cannulas. Thorax 1 août 1992;47(8):609–611.
34.
go back to reference Wettstein RB, Shelledy DC, Peters JI. Delivered oxygen concentrations using low-flow and high-flow nasal cannulas. Respir Care 1 mai 2005;50(5):604–609. Wettstein RB, Shelledy DC, Peters JI. Delivered oxygen concentrations using low-flow and high-flow nasal cannulas. Respir Care 1 mai 2005;50(5):604–609.
35.
go back to reference Sim MAB, Dean P, Kinsella J, Black R, Carter R, Hughes M. Performance of oxygen delivery devices when the breathing pattern of respiratory failure is simulated. Anaesthesia. 2008;63(9):938-40. Sim MAB, Dean P, Kinsella J, Black R, Carter R, Hughes M. Performance of oxygen delivery devices when the breathing pattern of respiratory failure is simulated. Anaesthesia. 2008;63(9):938-40.
36.
37.
go back to reference Frat J-P, Thille AW, Mercat A, Girault C, Ragot S, Perbet S, et al. High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure. N Engl J Med 4 juin 2015;372(23):2185–2196. Frat J-P, Thille AW, Mercat A, Girault C, Ragot S, Perbet S, et al. High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure. N Engl J Med 4 juin 2015;372(23):2185–2196.
38.
go back to reference SRLF Trial Group. Hypoxemia in the ICU: prevalence, treatment, and outcome. Ann Intensive Care 1 déc 2018;8(1):82. SRLF Trial Group. Hypoxemia in the ICU: prevalence, treatment, and outcome. Ann Intensive Care 1 déc 2018;8(1):82.
39.
go back to reference Duprez F, Mashayekhi S, Cuvelier G, Legrand A, Reychler G. A new formula for predicting the fraction of delivered oxygen during low-flow oxygen therapy. Respir Care 1 déc 2018;63(12):1528–1534. Duprez F, Mashayekhi S, Cuvelier G, Legrand A, Reychler G. A new formula for predicting the fraction of delivered oxygen during low-flow oxygen therapy. Respir Care 1 déc 2018;63(12):1528–1534.
40.
go back to reference Walsh BK, Smallwood CD. Pediatric oxygen therapy: a review and update. Respir Care. 2017;62(6):645–61.CrossRef Walsh BK, Smallwood CD. Pediatric oxygen therapy: a review and update. Respir Care. 2017;62(6):645–61.CrossRef
41.
go back to reference Jubran A. Pulse oximetry. Crit Care 16 juill 2015;19:272. Jubran A. Pulse oximetry. Crit Care 16 juill 2015;19:272.
42.
go back to reference Seifi S, Khatony A, Moradi G, Abdi A, Najafi F. Accuracy of pulse oximetry in detection of oxygen saturation in patients admitted to the intensive care unit of heart surgery: comparison of finger, toe, forehead and earlobe probes. BMC Nurs 17 avr 2018;17:15. Seifi S, Khatony A, Moradi G, Abdi A, Najafi F. Accuracy of pulse oximetry in detection of oxygen saturation in patients admitted to the intensive care unit of heart surgery: comparison of finger, toe, forehead and earlobe probes. BMC Nurs 17 avr 2018;17:15.
43.
go back to reference Cole CH, Wright KW, Tarnow-Mordi W, Phelps DL. Resolving our uncertainty about oxygen therapy. Pediatrics 1 déc 2003;112(6):1415–9. Cole CH, Wright KW, Tarnow-Mordi W, Phelps DL. Resolving our uncertainty about oxygen therapy. Pediatrics 1 déc 2003;112(6):1415–9.
44.
go back to reference Finer NN, Rich WD. Neonatal resuscitation: raising the bar. Curr Opin Pediatr. 2004;16.2:157-62. Finer NN, Rich WD. Neonatal resuscitation: raising the bar. Curr Opin Pediatr. 2004;16.2:157-62.
45.
go back to reference Tin W. Oxygen therapy: 50 years of uncertainty. Pediatrics. 2002;110(3):615–6.CrossRef Tin W. Oxygen therapy: 50 years of uncertainty. Pediatrics. 2002;110(3):615–6.CrossRef
46.
go back to reference Anderson CG, Benitz WE, Madan A. Retinopathy of prematurity and pulse oximetry: a national survey of recent practices. J Perinatol. 2004;24(3):164.CrossRef Anderson CG, Benitz WE, Madan A. Retinopathy of prematurity and pulse oximetry: a national survey of recent practices. J Perinatol. 2004;24(3):164.CrossRef
47.
go back to reference Higgins RD, Bancalari E, Willinger M, Raju TN. Executive summary of the workshop on oxygen in neonatal therapies: controversies and opportunities for research. Pediatrics. 2007;119(4):790–6.CrossRef Higgins RD, Bancalari E, Willinger M, Raju TN. Executive summary of the workshop on oxygen in neonatal therapies: controversies and opportunities for research. Pediatrics. 2007;119(4):790–6.CrossRef
48.
go back to reference Walsh M, Engle W, Laptook A, Kazzi SNJ, Buchter S, Rasmussen M, et al. Oxygen delivery through nasal cannulae to preterm infants: can practice be improved? Pediatrics. 2005;116(4):857–61.CrossRef Walsh M, Engle W, Laptook A, Kazzi SNJ, Buchter S, Rasmussen M, et al. Oxygen delivery through nasal cannulae to preterm infants: can practice be improved? Pediatrics. 2005;116(4):857–61.CrossRef
49.
go back to reference Sola A, Saldeno YP, Favareto V. Clinical practices in neonatal oxygenation: where have we failed? What can we do? J Perinatol. 2008;28(S1):S28.CrossRef Sola A, Saldeno YP, Favareto V. Clinical practices in neonatal oxygenation: where have we failed? What can we do? J Perinatol. 2008;28(S1):S28.CrossRef
50.
go back to reference Branson RD. Oxygen Therapy in COPD Respir Care 1 juin 2018;63(6):734–748. Branson RD. Oxygen Therapy in COPD Respir Care 1 juin 2018;63(6):734–748.
51.
go back to reference O’Driscoll BR, Howard LS, Earis J, Mak V. British Thoracic Society guideline for oxygen use in adults in healthcare and emergency settings. BMJ Open Respir Res. 2017;4(1):e000170.CrossRef O’Driscoll BR, Howard LS, Earis J, Mak V. British Thoracic Society guideline for oxygen use in adults in healthcare and emergency settings. BMJ Open Respir Res. 2017;4(1):e000170.CrossRef
52.
go back to reference Green R. Green’s Respiratory Therapy: A practical and essential tutorial on the core concepts of respiratory care. Chula Vista: Aventine Press; 2017. Green R. Green’s Respiratory Therapy: A practical and essential tutorial on the core concepts of respiratory care. Chula Vista: Aventine Press; 2017.
53.
go back to reference Hansen EF, Hove JD, Bech CS, Jensen J-US, Kallemose T, Vestbo J. Automated oxygen control with O2matic® during admission with exacerbation of COPD. Int J Chron Obstruct Pulmon Dis 14 déc 2018;13:3997–4003. Hansen EF, Hove JD, Bech CS, Jensen J-US, Kallemose T, Vestbo J. Automated oxygen control with O2matic® during admission with exacerbation of COPD. Int J Chron Obstruct Pulmon Dis 14 déc 2018;13:3997–4003.
54.
go back to reference West JB. Respiratory physiology: the essentials. Philadelphia: Lippincott Williams & Wilkins; 2012. West JB. Respiratory physiology: the essentials. Philadelphia: Lippincott Williams & Wilkins; 2012.
55.
go back to reference Ye L, Argha A, Yu H, Celler BG, Nguyen HT, Su S. Dynamic characteristics of oxygen consumption. Biomed Eng OnLine 23 avr 2018;17:44. Ye L, Argha A, Yu H, Celler BG, Nguyen HT, Su S. Dynamic characteristics of oxygen consumption. Biomed Eng OnLine 23 avr 2018;17:44.
58.
go back to reference Zoladz JA, Grassi B, Majerczak J, Szkutnik Z, Korostyński M, Grandys M, et al. Mechanisms responsible for the acceleration of pulmonary V̇o2 on-kinetics in humans after prolonged endurance training. Am J Physiol-Regul Integr Comp Physiol 27 août 2014;307(9):R1101–R1114. Zoladz JA, Grassi B, Majerczak J, Szkutnik Z, Korostyński M, Grandys M, et al. Mechanisms responsible for the acceleration of pulmonary V̇o2 on-kinetics in humans after prolonged endurance training. Am J Physiol-Regul Integr Comp Physiol 27 août 2014;307(9):R1101–R1114.
59.
go back to reference Haddad A, Zhang Y, Su S, Celler B, Nguyen H. Modelling and regulating of cardio-respiratory response for the enhancement of interval training. Biomed Eng OnLine 6 févr 2014;13:9. Haddad A, Zhang Y, Su S, Celler B, Nguyen H. Modelling and regulating of cardio-respiratory response for the enhancement of interval training. Biomed Eng OnLine 6 févr 2014;13:9.
60.
go back to reference Zhang Y, Haddad A, Su SW, Celler BG, Coutts AJ, Duffield R, et al. An equivalent circuit model for onset and offset exercise response. Biomed Eng Online 18 oct 2014;13:145. Zhang Y, Haddad A, Su SW, Celler BG, Coutts AJ, Duffield R, et al. An equivalent circuit model for onset and offset exercise response. Biomed Eng Online 18 oct 2014;13:145.
61.
go back to reference Cao Z, Luo Z, Hou A, Nie Q, Xie B, An X, et al. Volume-targeted versus pressure-limited noninvasive ventilation in subjects with acute hypercapnic respiratory failure: a multicenter randomized controlled trial. Respir Care. 2016:respcare–04619. Cao Z, Luo Z, Hou A, Nie Q, Xie B, An X, et al. Volume-targeted versus pressure-limited noninvasive ventilation in subjects with acute hypercapnic respiratory failure: a multicenter randomized controlled trial. Respir Care. 2016:respcare–04619.
62.
go back to reference Couture MA. PaO2/FIO2 is not a Guesstimation. Respir Care. 2017;62(3):388–9.CrossRef Couture MA. PaO2/FIO2 is not a Guesstimation. Respir Care. 2017;62(3):388–9.CrossRef
63.
go back to reference Luo Z, Cao Z. PaO2/FIO2 is not a Guestimation—reply. Respir Care 1 mars 2017;62(3):389–389. Luo Z, Cao Z. PaO2/FIO2 is not a Guestimation—reply. Respir Care 1 mars 2017;62(3):389–389.
64.
go back to reference Paxman T, Noga M, Finlay WH, Martin AR. Experimental evaluation of pressure drop for flows of air and heliox through upper and central conducting airway replicas of 4- to 8-year-old children. J Biomech 3 janv 2019;82:134–141. Paxman T, Noga M, Finlay WH, Martin AR. Experimental evaluation of pressure drop for flows of air and heliox through upper and central conducting airway replicas of 4- to 8-year-old children. J Biomech 3 janv 2019;82:134–141.
65.
go back to reference Tavernini S, Church TK, Lewis DA, Noga M, Martin AR, Finlay WH. Deposition of micrometer-sized aerosol particles in neonatal nasal airway replicas. Aerosol Sci Technol 3 avr 2018;52(4):407–419. Tavernini S, Church TK, Lewis DA, Noga M, Martin AR, Finlay WH. Deposition of micrometer-sized aerosol particles in neonatal nasal airway replicas. Aerosol Sci Technol 3 avr 2018;52(4):407–419.
66.
go back to reference Bachman TE, Newth CJL, Iyer NP, Ross PA, Khemani RG. Hypoxemic and hyperoxemic likelihood in pulse oximetry ranges: NICU observational study. Arch Dis Child Fetal Neonatal Ed 20 juin 2018; Bachman TE, Newth CJL, Iyer NP, Ross PA, Khemani RG. Hypoxemic and hyperoxemic likelihood in pulse oximetry ranges: NICU observational study. Arch Dis Child Fetal Neonatal Ed 20 juin 2018;
67.
go back to reference Helmerhorst HJF, Arts DL, Schultz MJ, van der Voort PHJ, Abu-Hanna A, de Jonge E, et al. Metrics of arterial Hyperoxia and associated outcomes in critical care. Crit Care Med févr 2017;45(2):187–195. Helmerhorst HJF, Arts DL, Schultz MJ, van der Voort PHJ, Abu-Hanna A, de Jonge E, et al. Metrics of arterial Hyperoxia and associated outcomes in critical care. Crit Care Med févr 2017;45(2):187–195.
Metadata
Title
Dose variability of supplemental oxygen therapy with open patient interfaces based on in vitro measurements using a physiologically realistic upper airway model
Authors
Ira Katz
John Chen
Kelvin Duong
Kaixian Zhu
Marine Pichelin
Georges Caillibotte
Andrew R. Martin
Publication date
01-12-2019
Publisher
BioMed Central
Published in
Respiratory Research / Issue 1/2019
Electronic ISSN: 1465-993X
DOI
https://doi.org/10.1186/s12931-019-1104-0

Other articles of this Issue 1/2019

Respiratory Research 1/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine